Progress in Pharmacological Actions of Ginsenoside Compound K,an Active Metabolite of Protopanaxadiol Type Saponins

LI Xiang-peng,WANG Peng,LI Ying-xia

DOI: https://doi.org/10.3867/j.issn.1000-3002.2011.01.019

2011-01-01

Abstract:Ginsenoside compound K(CK),20-O-β-(D-glucopyranosyl)-20(S)-protopanaxadiol,is a major form of protopanaxadiol type saponins absorbed by the human body after oral administration,and a real component that mediates pharmacologic actions.Recently,new progress has been made in studies on pharmacological actions:① CK can activate caspase 8,which plays a key role in CK-stimulated apoptosis via activation of caspase 3 directly or indirectly through mitochondria pathway and can regulate the metastasis and invasiveness of tumor cells by down-regulating metalloproteinase 9 gene expression;② CK can reduce expression levels of NO synthase and cyclooxygenase-2 and inhibit secretion of some pro-inflammatory cytokines like interleukin 4(IL-4),IL-6 or tumor necrosis factor-α,which are responsible for its anti-inflammatory,anti-allergic,and neuro-protective activities;③ CK can enhance the insulin secretion by blocking the ATP sensitive K+ channel,improve insulin sensitivity,and shift glucose metabolisim from hepatic glucose production to hepatic glucose utilization in the liver,suggesting that CK be a therapeutic reagent for type 2 diabetic patients;④ CK can prevent the ultraviolet radiation induced skin damage by up-regulating nucleotide excision repair gene expression.